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Abstract
Introduction: Of the complications following pancreatodu-
odenectomy (PD), postpancreatoduodenectomy hemor-
rhage (PPH) is the least common, but severe forms can be 
life-threatening without urgent treatment. While early PPH 
is mostly related to surgical hemostasis, late PPH is more like-
ly due to complex physiopathological pathways secondary 
to different etiologies. The understanding of such etiologies 
could therefore be of great interest to help guide the treat-
ment of severe, potentially life-threatening, late PPH cases. 
Objective: The aim of this retrospective study was to assess 
the causes of PPH as a complication and explore a possible 
association between the causes and the severity of late PPH. 
Methods: A retrospective study was performed at the HPB 
and Surgical Oncology Unit, Rambam Health Care Campus, 
Haifa, Israel. The charts of all patients submitted for PD were 
reviewed, and all patients with PPH were included. The tim-
ing, cause, and severity of PPH as well as other information 
were collected. A statistical analysis on the possible associa-
tion between cause and severity of late PPH was performed. 
Results: A total of 347 patients underwent PD, 18 of whom 
(5.18%) developed PPH. Early PPH was reported in 1 patient 
(5.6%) with severe bleeding from the gastric staple line. Late 
PPH was reported in 17 patients (94.4%). The most common 
causes of late PPH were bleeding from a vascular pseudoan-
eurysm (PSA) reported in 6 patients, 1 with mild and 5 with 
severe hemorrhage, and bleeding from a gastroenteric anas-
tomosis marginal ulcer reported in 6 patients, all with mild 
hemorrhage. No etiology was found in 5 patients with mild 
hemorrhage. A significant association was found between 
the severity of late hemorrhage and vascular PSA as the 
cause of the bleeding (p = 0.001). All PSA bleeding occurred 
in cases complicated by a postoperative pancreatic fistula 
(POPF), with a significant statistical association (p < 0.001). 
Conclusions: The most common cause of PPH was bleeding 
from a vascular PSA; the majority of these cases involved se-
vere bleeding with late presentation, and all were associated 
with a POPF formation. In such cases, early detection by 
computed tomography angiography is mandatory, thereby 
promoting urgent treatment by angiography of vascular 
bleeding complications following PD.
© 2020 S. Karger AG, Basel
Introduction
Pancreatoduodenectomy (PD) is a complex, highly 
challenging operation to perform. The first successful 



























   
   
   
   
   
   
   
   
























he successfully anastomosed the pancreatic duct to the je-
junum [1]. Although Whipple was the first to report the 
single-stage PD procedure, Verne Hunt was the first sur-
geon to successfully restore pancreaticoenteric anastomo-
sis following PD in 1941 [2]. PD is the surgical procedure 
of choice for the treatment of benign and malignant dis-
eases of the periampullary region (the head of the pancreas, 
ampulla of Vater, distal common bile duct, and second part 
of the duodenum), severe trauma to the pancreatic head 
and duodenum, and highly selective cases of chronic pan-
creatitis [3, 4]. The mortality rate following PD was ini-
tially high at almost 25%, but, as a result of the develop-
ment of specialized centers, along with the improvement 
in perioperative care and advances in surgical techniques, 
mortality rates have fallen to < 1%, especially in high-vol-
ume centers [5–8]. Nevertheless, the morbidity rate follow-
ing PD remains high, with almost 30–40% of patients de-
veloping ≥1 complication [9, 10]. The most common com-
plications following PD are delayed gastric-emptying, 
postoperative pancreatic fistula (POPF), intra-abdominal 
collections, biliary anastomotic leakage and post-PD hem-
orrhage (PPH), the last being the least frequent to occur. 
The incidence rate of PPH is 5–16%, with severe bleeding 
occurring in < 10% of patients. The condition may be life-
threatening if urgent treatment is not performed, and it is 
usually associated with high morbidity and mortality, es-
pecially if surgical intervention is required [11, 12].
According to the International Study Group of Pan-
creatic Surgery (ISGPS), PPH can be classified into early 
and late PPH [13, 14]. While early PPH is mostly related 
to surgical hemostasis, late PPH is more likely due to 
more complex physiopathological pathways. PPH that 
develops early following the index operation can be due 
to bleeding vessels (branches of the portal vein or the su-
perior mesenteric artery [SMA]), or bleeding from one of 
the anastomoses. Late PPH could be due to a marginal 
ulcer (mostly at the gastroenteric anastomosis) or a bleed-
ing vascular pseudoaneurysm (PSA), mostly involving 
the gastroduodenal artery (GDA) stump, and may devel-
op following pancreatic leak and vessel erosion [15]. 
The understanding of the etiology of such a pathway 
could therefore be of great interest in cases of severe hem-
orrhage to guide the treatment of a potentially life-threat-
ening condition that could be otherwise preventable. The 
aim of this retrospective study was to assess the cause of 
PPH as a complication and explore the possible associa-
tion between the cause and severity of late PPH.
Methods
A retrospective study over a period of 8 years, from 1 January 
2011 to 31 December 2018, was performed at the Hepato-Pancre-
ato-Biliary (HPB) Unit of the General Surgery Department at 
Rambam Health Care Campus, Haifa, Israel. All patients aged ≥18 
years who underwent PD were included in the study. Patients who 
underwent PD for severe trauma to the pancreatic head or duode-
num, or other forms of pancreatic resection such as distal or total 
pancreatectomy, were excluded from the study. Patients were 
checked for readmission to our hospital or to other medical cen-
ters.
The 3 main outcomes were: timing of onset, cause of hemor-
rhage, and severity of hemorrhage. Other data included clinical 
manifestation of the hemorrhage, investigational modules used for 
diagnosis, management, and mortality rate. Possible risk factors 
for PPH relating to both surgical complications (e.g., POPF, intra-
abdominal abscess) and the patient (e.g., anticoagulant or antiag-
gregant therapy and final pathology) were also registered.
Timing of PPH was classified according to the ISGPS, into ear-
ly and late PPH; early is when the bleeding occurs within 24 h of 
the index operation and late is when bleeding develops > 24 h after 
it [14, 15].
Causes of PPH were defined by the lesion found at the site of 
the bleeding. The cause was classified as unknown when no bleed-
ing site was found on CT scan or endoscopy according to the clin-
ical manifestation of the bleeding.
The severity of the hemorrhage was classified according to the 
ISGPS criteria into: mild PPH in case of small-medium blood loss 
(a decrease in hemoglobin level < 3 g/dL) which leads to mild clin-
ical impairment, and severe PPH (a decrease in hemoglobin level 
of ≥3 g/dL) which usually results in hemodynamic instability [14, 
15].
The cases of POPF were registered according to the classifica-
tion reported by Bassi et al. [16], with grade A POPF being replaced 
by biochemical leak.
Since it is in late PPH that the knowledge of a possible associa-
tion between the cause and severity of PPH could be of interest in 
planning treatment, this association was statistically tested by 
comparing the respective frequency of causes in patients with mild 
PPH and patients with severe PPH. 
The role of possible risk factors for PPH was investigated by 
comparing their frequency in patients without PPH and patients 
with PPH in a univariate analysis. The analysis was completed by 
investigating a possible association between clinically relevant po-
tential risk factors, such as surgical complications and PSA as ma-
jor causes of late PPH, by comparing the respective rates in patients 
with and without bleeding PSA. 
Continuous variables are summarized as mean and SD and dis-
crete variables are categorically expressed as n (%). Student’s t test 
was used for continuous variables. The χ2 or Fisher’s exact test, 
depending on the results, was used for variables that were dichoto-
mous. A p value < 0.05 was considered significant. 
Results
During the study period, 347 patients underwent PD 
for the management of diseases in the periampullary re-
gion. PPH was registered in 18 patients (5.2%), 10 males 
and 8 females (ratio 1.25: 1). The average age was 68 years 
(range 22–85 years). 
As reported in Table 1 and Figure 1, the timing of the 
bleeding was early in 1 patient (5.6%), and late in 17 
(83.3%). The patient with early PPH had severe bleeding 
from the gastric staple line. In the cases of late PPH, the 
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in 6 patients (1 with mild and 5 with severe hemorrhage) 
and bleeding from a gastroenteric anastomosis marginal 
ulcer in 6 patients (all with mild hemorrhage). No etiol-
ogy was found in 5 patients with mild hemorrhage. Over-
all, hemorrhage was mild in 12 (66.6%) and severe in 6 
(33.3%) patients. According to the ISGPS classification, 
no Grade A bleeding was observed, 13 patients had Grade 
B bleeding, and 5 had Grade C bleeding.
Blood discharge from the drain was the most common 
presentation and was reported in 11 patients (61.1%). As 
our routine practice, 2 Jackson-Pratt drains are placed in 
the abdominal cavity of all patients undergoing PD. These 
are stationed in the right upper abdominal space near the 
pancreatico- and hepatico-jejeunal anastomosis. Patients 
are usually discharged with the drains and then followed 
up at our outpatient clinic a week later. Of these patients 
with blood discharge from the drain, 8 had been previ-
ously diagnosed with POPF, and none had sentinel bleed-
ing into the drains upon their discharge. A total of 7 pa-
tients (38.9%) presented with signs of upper gastrointes-
tinal bleeding, with hematemesis reported in 6 and a 
continuous bloody discharge from the nasogastric tube in 
the remaining patient. 
The patient with early severe hemorrhage was hemo-
dynamically unstable. Urgent surgery was performed. 
Active bleeding from the gastric staple line was found and 
a hemostatic suture was used to stop the bleeding. During 
PD at our center, gastroenterostomy anastomosis is per-
formed by means of a circular staple inserted through an 
anterior wall gastrostomy, which is, in turn, closed with a 
linear staple afterwards. 
In the cases of late PPH, vascular PSA was the cause of 
bleeding in 6 patients, involving the GDA in 5 cases and 
the inferior pancreaticoduodenal artery in 1. One was a 
mild case and 5 involved severe hemorrhage. Computed 
tomography angiography (CTA) was diagnostic for all 
cases of bleeding PSA, which indicates a high specificity 
of this exam in the diagnosis of PPH. All patients were 
successfully treated by means of angiographic emboliza-
tion using different methods. 
Bleeding from a marginal ulcer of the gastroenteric 
anastomosis was found in 6 patients, all of whom had un-
dergone PD with a Roux-en-Y reconstruction. PPH was 
late with mild hemorrhage in all of them. All were treated 
by endoscopy and had an average of 2 units of packed red 
blood cells (PRBC) transfused. 
All patients with bloody discharges from the drain and 
an unknown etiology upon completing a hemorrhage 
screen workup presented as late PPH. A negative CTA 
scan and negative endoscopy were reported in 4 cases, 
while no diagnostic tests were performed in 1 case of lim-
ited bloody discharges from the drain. All cases were 
treated conservatively, with transfusion of an average of 
3 units of PRBC per patient. In all cases, the bleeding re-
sponded to conservative treatment, leaving no merit to 
performing a surgical intervention. 
Urgent surgery was performed in 1 patient due to 
hemorrhagic shock. Urgent CTA was performed in 10 
patients with bloody discharge from the drain. Urgent en-
doscopy was performed in 6 patients with gastrointestinal 
bleeding. In 1 patient with mild hemorrhage, no diagnos-
tical tests were performed. No mortality was registered 
due to PPH.
For the statistical analysis evaluating the association 
between the cause and severity of PPH, no severe bleeding 
from marginal ulcers and no severe unknown hemor-
rhage were diagnosed, so no χ2 test was conducted. By 
grouping unknown etiology with marginal ulcer bleed-
ing, PSA was found to be significantly associated with se-
vere hemorrhage. The rate of PSA was 100% in patients 
with severe bleeding compared to 8.3% in patients with 
mild hemorrhage (p = 0.001, Fisher’s exact test).
As reported in Table 2, no significant association was 
found between possible risk factors for PPH (whether re-
lating to surgical complications or patients) and the inci-
dence rate. The overall rate of POPF was 26%, but this 
complication occurred in 8 (44.4%) patients with PPH, all 
Table 1. Summary of timing, site of bleeding, and severity of PPH
Mild Severe Total
Early
Gastric stapler line 0 1 1
Late
Pseudoaneurysm 1 5 6
Marginal ulcer 6 0 6
Unknown 5 0 5
Total 12 6 18



























   
   
   
   
   
   
   
   
























of whom had a biochemical leak. Although the difference 
in the rate of POPF in patients with and without PPH was 
19.4%, the association between POPF and PPH was not 
statistically significant (p = 0.07); however, the estimated 
power of such a comparison is < 50%. Moreover, although 
POPF was not found to be a risk factor for PPH, all pa-
tients who bled due to PSA were initially diagnosed with 
a biochemical leak (previously POPF grade A, according 
to the ISGPF definition of POPF). The association be-
tween POPF and PSA was found to be statistically sig-
nificant with a POPF rate of 100% in patients with bleed-
ing PSA and 26% in patients with no bleeding PSA (p < 
0.001), suggesting the potential role of POPF in the devel-
opment of a bleeding PSA as a cause of late PPH. 
Discussion
The results of this study show that most of the patients 
suffered from late PPH, and that bleeding vascular PSA 
was the most common cause of severe late PPH. More-
over, a significant association was found between vascu-
lar PSA bleeding and an initial diagnosis of POFP.
It was a retrospective study, but all consecutive pa-
tients treated in the period already mentioned were in-
cluded. Data are stored in a database that allows easy se-
lection of cases of interest based on diagnosis, interven-
tion, and postoperative complications. Rambam Health 
Care Campus is a referral center for 10 other hospitals 
that give medical cover for 2 million citizens, particularly 
all patients for whom major pancreatic surgery is indi-
cated. Our study should therefore be considered as hav-
ing a low risk of selection bias. 
Some concern should be advocated about the cases for 
which no etiology was found. A recent meta-analysis re-
ported a sensitivity of 56% for CTA in identifying the 
source of bleeding following pancreatectomy [17], so the 
high incidence of false-negative diagnoses could affect the 
association found between several causes of late severe 
bleeding. No details about the original studies were pro-
vided in the meta-analysis, but the low sensitivity of CTA 
scan in diagnosing vascular PSA could be explained by 
the intermittent characteristics of the bleeding in cases of 
PPH [18]. Data on gastrointestinal bleeding reported in a 
recent review suggest that, in cases of massive gastroin-
testinal bleeding, the sensitivity and specificity of CTA 
scan are much higher. Moreover, a negative CTA scan 
could be considered a good prognostic result, as patients 
with no bleeding evident on the scan are unlikely to have 
massive bleeding [19]. This observation may be valid for 
gastrointestinal bleeding, but no data on PSA as a cause 
of PPH were found. According to a recent review, a self-
limiting episode of bleeding, so-called sentinel bleeding, 
may be the initial manifestation of PPH [18]. In these cas-
es, CTA scan may also be negative, but extra caution must 
be exercised due to the fact that sentinel bleeding may 
precede a severe PPH in 50–80% of cases, thus requiring 
intensive monitoring and specific diagnostic workup. In 
our series, the cases of bleeding with an unknown origin 
should not be considered as sentinel bleeding since they 
Table 2. A comparison between patients with and without PPH
Patients with PPH Patients without PPH p value
Number of patients 18 329
Average age, years (range) 68 (22–85) 64 (19–86) 0.16
Male-to-female ratio 1.25 1.27 0.97
Anticoagulant/antiaggregant treatment 15 (83.3) 279 (84.8) 0.87
Roux-en-Y classic PD performed 18 (100) 329 (100) 1
POPF 8 (44.4) 82 (24.9) 0.07
Intra-abdominal abscess 2 (11.1) 36 (10.9) 1
Pathology
PDA 10 (55.5) 201 (61.1) 0.64
IPMN high-grade dysplasia 3 (16.7) 46 (14) 0.73
IPMN low-grade dysplasia 1 (5.6) 29 (8.8) 0.44
Neuroendocrine tumor 1 (5.6) 9 (2.7) 0.42
Duodenal adenocarcinoma 1 (5.6) 9 (2.7) 0.42
Distal CBD/ampulla adenocarcinoma 0 26 (7.9) 0.38
Pancreatic papillary pseudotumor 0 2 (0.6) 1
Normal pancreas 2 (11.1) 7 (2.1) 0.07
Values express n (%), unless otherwise indicated. PPH, postpancreatectomy hemorrhage; PD, pancreatoduo-
denectomy; PDA, pancreatic ductal adenocarcinoma; IPMN, intraductal papillary mucinous neoplasm; CBD, 
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were all self-limited and no further hemorrhage was ob-
served in any of them. 
Recent published studies on PPH have no homoge-
nous methodology. A literature research limited to the 
past 10 years found studies reporting PPH complicating 
a series of pancreatectomies [20–26]. Others, like this 
study, have focused on PD [27–33], and some report re-
sults mainly related to late PPH [26, 30, 32]. Other studies 
produced results about the treatment of PPH cases [34–
44] and focused mainly on series of late PPH. In 1 series, 
PPH was classified according to the timing as early, inter-
mediate, or late, but the only reported cases were inter-
mediate or late [45]. 
The reported rate of PPH varies from 3 to 16.8% across 
studies, i.e., those covering all types of pancreatectomy 
[20–26], and those focusing on PD [27–29, 31, 45]. Only 
a handful has reported a rate > 10% [21, 24, 26, 29]. All 
series also reported that late PPH occurred more fre-
quently than early PPH, with a rate > 75% compared to 
90% in our study. Only 1 study from Italy [26] reported a 
rate of late presentation of 45%. This particular study had 
the biggest series of pancreatectomies, 2,429 cases in 13 
years; the lower rate of late PPH is related to the finding 
that 77% of the patients had Grade B bleeding. The over-
all rate of late PPH as a complication of pancreatic surgery 
varies from 2.3 to 13.1% in the more recent studies [20, 
22, 23, 25–27, 29–33]. These results are comparable to 
previous studies included in a meta-analysis that reported 
an overall rate of late PPH of 3.3% (range 1.6–12.3%) [46].
Severe late PPH, classified as Grade C by the ISGPS, is, 
however, the less common type. In our study, 29.4% of 
late PPH cases were severe. The data reported in the lit-
erature ranges mainly from 26.6 to 53.8% [20, 22, 23, 25, 
26, 30–33]. However, 1 small series of 87 PD in over 3 
years reported a rate of severe late PPH of 90% [27]. 
As recommended in a recent review, the best approach 
should be tailored based on the clinical manifestation and 
the timing and severity of the bleeding [18]. However, the 
cause of bleeding also plays a role in PPH treatment strat-
egy. Intraluminal bleeding may be approached by endos-
copy first, while CTA is preferred for extraluminal bleed-
ing. In cases where the site of bleeding cannot be found at 
the first examination, a diagnostic workup should be 
completed [47]. Based on nonanalytic data, some authors 
suggest performing a CTA scan, even in cases of a diag-
nosed cause of intraluminal bleeding on endoscopy. The 
finding of a mild bleeding cause might distract the physi-
cian from further severe bleeding causes, which can delay 
intervention and worsen the outcome [18]. This conclu-
sion is not confirmed by the data of our study. 
In all cases of intraluminal bleeding, a cause was found 
at endoscopy. In the cases of extraluminal bleeding, the 
cause was found in only 6/10 patients. In patients with no 
apparent cause of bleeding, a full thorough diagnostic 
workup was completed, with a negative endoscopy in all 
cases. All 4 of these patients manifested with self-limited 
bleeding with no clinical worsening of the PPH. 
Early PPH is usually due to the technical failure of he-
mostatic factors used during surgery, and it can be mild 
or severe. In our study, 1 patient developed early PPH, 
manifesting as a bloody discharge from the nasogastric 
tube. Due to continuous bleeding, along with a severe de-
crease in hemoglobin level, she underwent a reoperation, 
during which a bleeding from the gastric staple line was 
detected, a primary suture was placed, and the bleeding 
stopped.
Late bleeding could be due to marginal ulcers, or bleed-
ing from the resection bed, the anastomosis, or the vascu-
lar stump, or an arterial PSA. The majority of our patients 
suffered from late PPH (94.4%), with a bleeding vascular 
PSA the most common cause of late severe bleeding (6/17 
patients, 5 with a GDA PSA and 1 with an inferior pan-
creaticoduodenal artery PSA). Recent studies focusing on 
PD [27–33, 45] have confirmed that the GDA stump is 
the most common site of bleeding. However, the clear 
description of a PSA is not always reported, and it may 
not always be clear whether the bleeding indeed arose 
from direct leakage from the artery stump, or a PSA that 
formed after surgery. Of 7 PSA cases, an extravasation of 
contrast material (suggesting active bleeding) was ob-
served in only 2 patients, and 2 others showed signs of 
active bleeding with no PSA reported [31].
As a result, the exact prevalence of PSA in cases of late 
PPH may be underestimated. The rate of PSA as a cause 
of late severe bleeding is reported to be 28.5–38.8% in late 
PPH [17–19, 35, 44]. A statistical association between 
PSA and bleeding has not yet been explored. The most 
interesting finding of our study was the statistically sig-
nificant association between late severe bleeding and ar-
terial PSA as a cause of bleeding. Moreover, 83.3% of se-
vere bleeding was caused by PSA, and the second-most 
common site of bleeding was the pancreaticoduodenal 
artery, a rare site of bleeding that has previously been re-
ported only as a sight of sporadic bleeding [34, 37, 40]. 
Of the post-PD complications, POPF has been report-
ed to increase the risk of PPH and has been associated 
with late bleeding in 48.1–78.5% of cases [30, 31, 45]. Our 
finding of 44.4% of POPF in PPH could be considered 
congruous with the data reported in the literature. 
Interventional radiology (IR) has become a valuable di-
agnostic approach, allowing a definitive treatment by em-
bolizing or stenting bleeding arteries in cases of extralu-
minal PPH. All the cases in our study were treated success-
fully by IR. Whether embolization or stent placement 
insertion is performed depends mainly on the site of the 
bleeding as well as the length of the GDA stump. In cases 
of a short GDA stump, hepatic artery stenting to bypass 



























   
   
   
   
   
   
   
   
























while long GDA stumps are usually embolized with coils 
or glue (Table 3; Fig. 2–4). In 1 patient, the bleeding orig-
inated from a branch of the SMA, suspected to be the in-
ferior pancreaticoduodenal artery stump (Fig. 5). This al-
lowed a definitive treatment without major complications 
following the procedure. In the literature, the role of IR is 
well documented [34–44], but the reported success rate 
varies. Relapse bleeding, requiring more than an IR ap-
proach before treatment could be considered as definitive 
(reported in up to 47.6%) [36–44]. A failure of IR was re-
ported in up to 13% of cases in most of the studies [34, 36, 
38, 41, 43, 44], with 1 [42] reporting a failure rate of 35%.
Major hepatic complications have been reported in up 
to 23.8% of cases [48]. The risk of hepatic failure or he-
patic abscess formation increased when performing an 
embolization of the hepatic artery following a pancreatec-
tomy involving the head of the pancreas. In such cases, 
stenting is the preferred method of treatment.
Among PPH cases, a mortality rate ranging from 0 to 
39.7% has been reported, and is associated with early 
PPH, late PPH, and treatment complications [20, 22, 23, 
25, 26, 28–32, 34, 37–41, 43–45]. Studies focusing on late 
PPH report a mortality rate in the range of 7.1–23.8% [34, 
37–41, 43, 44]. In our study, no mortality was registered.











Presentation Findings on CTA Angiographic
management
1 80 M MD-IPMN PE, BL No hematemesis PSA of the GDA stent graft into the CHA 
(Fig. 2, 3)
2 84 M PDA BL No blood in drains PSA of the GDA stent graft into the CHA
3 67 F LG-PIN BL No blood in drains PSA of the GDA 
(Fig. 4)
coil embolization of the 
CHA
4 68 M PDA BL No hematemesis no active bleeding stent graft into the CHA
5 68 M PDA BL No hematemesis active bleeding from 
branch of SMA (Fig. 5)
glue embolization 
6 74 F PDA BL No blood in drains PSA of the GDA stent graft into the CHA
M, male; F, female; PD, pancreaticoduodenectomy; MD-IPMN, main duct intraductral mucinous neoplasm; PDA, pancreatic duct 
adenocarcinoma; LG-PIN, low-grade pancreatic intraepithelial neoplasm; PE, pulmonary embolism; BL, biochemical leak; CTA, 
computed tomography angiography; PSA, pseudoaneurysm; GDA, gastroduodenal artery; IPDA, inferior pancreaticoduodenal artery; 
CHA, common hepatic artery; SMA, superior mesentric artery.
Fig. 2. Selective angiography of the celiac artery reveals PSA of the 
GDA (arrow).
Fig. 3. Control of bleeding was achieved by stent insertion into the 
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The results of our study confirm most of the literature 
findings on PPH and include clinical presentations and 
late severe PPH treatment. A significant association be-
tween severe late PPH and PSA bleeding is of clinical 
importance. A finding of 1 PSA with mild bleeding sug-
gests that PSA may form with no initial clinical impor-
tance but may nevertheless cause severe hemorrhage in 
the following stages. Although this would not alter the 
therapeutic approach, it should also be studied, to distin-
guish true PSA from bleeding secondary to arterial stump 
leakage. 
Conclusion
PPH is a less common, yet well-known complication 
following PD, with a wide range of incidence rates. A sig-
nificant association was found between the cause and se-
verity of the bleeding, with PSA as the cause of all severe 
cases of late PPH, and a bleeding marginal ulcer as the 
cause of mild PPH. POPF was also found to be associated 
with PSA, which, in turn, was the major cause of late se-
vere bleeding. In future studies, the distinction between 
true PSA and arterial stump leakage should be made.
Statement of Ethics
This article does not contain any experimental studies with hu-
man participants or animals performed by any of the authors. The 
study was approved by the Ethics Committee. Due to the retro-
spective nature of the study, informed consent was waived. The 
study was approved by the review board of our Department.
Conflict of Interest Statement
The authors have no conflicts of interest to declare.
Funding Sources
There were no funding sources.
Author Contributions
Acquisition of the data was made by Ameer Azzam and Amir 
Obeid and analysis and interpretation were done by Safi Khuri. 
The paper was drafted by Safi Khuri and Subhi Mansour, and crit-
ical revision and final approval of the published version was done 
by Yoram Kluger and Giuseppe Borzellino. All parties agree to be 
accountable for all aspects of the work in ensuring that questions 
related to the accuracy or integrity of any part of the work are ap-
propriately investigated and resolved.
Fig. 4. On abdominopelvic CTA, a PSA of the GDA was demon-
strated with contrast blush (arrow). A J-P drain inserted during 
operation can be seen next to the bleeding site.
Fig. 5. Selective angiography of the superior mesenteric artery 
(SMA), showing an active bleeding from a branch of the SMA sus-
pected to be from the inferior pancreaticoduodenal artery stump 
(arrow).
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